Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice

Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice is organized by UK HealthCare CECentral.

Release: Oct 31, 2017
Expires: Mar 18, 2025

Needs Statement:
KASPER and UDS/T can be used as therapeutic clinical tools to help monitor for unintended adverse effects of prescribed opioids (and other controlled drugs with known abuse potential and increasing presence in overdose death cases such as the opioids and benzodiazepines) and to help health providers not be unintentional sources of diverted medications. This process can get providers talking more to patients (and their family/friends) about the need for safe storage, diversion, misuse, and substance use disorder that impacts patients and public health.

Objectives:
Upon completion of this educational activity, you will be able to:
• Interpret and verify a KASPER report
• Understand how to have appropriate conversations with patients about unexpected KASPER report results 
• Review metabolism of commonly prescribed pain pills that can affect interpretation of urine drug test and give case examples of common misinterpreted results
• Explain the differences between urine screens vs. tests

Additional details will be posted as soon as information is available.